API Product

Fluticasone Furoate

Product Status:
Available Grades:
  • Inhalation
Regulatory Status:
Production Sites:
  • Hovione Loures
Product Type:
  • Corticosteroids
CAS Number:
Modes of Application:
  • Nasal
Common Indications:
  • COPD
Last Inspection:
FDA May 2018

Hovione offer Fluticasone Furoate, crystalline form I for development trials with tailor made particle design to best fit your application, yielding Inhalation grade material, featuring a near-perfect particle size distribution reproducibility and low span batch after batch.

Low amorphous content and high stability with >99.60% purity are also features of this API.

With a proven track record in developing and manufacturing high performance APIs Hovione offers a full range of API inhalation, e.g. Vilanterol Trifenatate or Umeclidinium Bromide.

This is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties’ patent rights.

Related files

Hovione Product Portfolio
pdf (706.84 KB)